Testing effectiveness (Phase 2)Not Yet RecruitingNCT07307053
What this trial is testing
Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)
Who this might be right for
Rare Malignant NeoplasmAdvanced Solid TumorsMetastatic Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 600